SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (473)8/18/1997 1:46:00 PM
From: Andrew H   of 2173
 
>>Results at 12 months were NOT significant for Type II. Type I was statistically significant, but still had lots of room for improvement. The examples I discussed before the open were for Type I.<<

Yes, of course. It was too early in the morning for me. I meant to write "Type 1." Those results were clearly less than compelling. The Type 2 results were not only not compelling but disappointing.

You are right that there is nothing to be happy about here. I had expected better from AMLN. The sector seems to be unhurt, though.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News